Le Lézard
Classified in: Science and technology, Business
Subject: RESTRUCTURING/RECAPITALIZATION

Keek Inc. Announces Name Change to Peeks Social Ltd.


TORONTO, ON--(Marketwired - March 02, 2017) - Keek Inc. (TSX VENTURE: KEK) (OTCQB: KEEKF) is pleased to announce that it has changed its name to Peeks Social Ltd. The Company has also changed its stock trading symbol on the TSX Venture Exchange to PEEK. The common shares of the Company will commence trading under the new name and trading symbol at the opening of trading tomorrow, March 3, 2017. The Company is not subdividing, consolidating, or otherwise altering its share capital in association with the name change.

"Our corporate name change is a momentous occasion in the history of the Company, in that it marks the beginning of a brand new era. Our new name is a manifestation of our new vision, new management, new products, and renewed future. Much like our peers -- Facebook, Snapchat, and YouTube -- our name is our brand and now our brand is our name," said Mark Itwaru, CEO of the Company.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this Release.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: